Genetic testing for tripler army medical center, hawaii
Ended Blanket Purchase Agreement Awarded Last action
- Contract number
- W81K0220A0019
- Awardee
-
Fulgent Therapeutics LLC UEI JVZDRESJLD82 Part of Fulgent Genetics, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Task orders
- 0
Award facts
- Opportunity
-
- Genetic Testing for Tripler Army Medical Center, Hawaii Solicitation · W81K0220Q0177 · Posted Jul 8, 2020
- Last date to order 100% complete
- IDV ceiling
- $950,000.00
- Maximum order
- $250,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this IDV
Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, was awarded a $950,000 multiple-award Blanket Purchase Agreement by the Department of the Army Medical Command on September 8, 2020, for genetic testing services at Tripler Army Medical Center in Hawaii. The contract was awarded without set-aside designation following an open competitive solicitation posted on July 8, 2020, with a closing date of August 5, 2020. The BPA has an ultimate completion date of September 7, 2025, establishing a five-year performance period during which the contractor will provide comprehensive genetic testing and diagnostic services to support the military healthcare facility's clinical and research needs.
Under this agreement, Fulgent Therapeutics delivers advanced genetic testing capabilities including clinical genetic testing, genomic sequencing, and molecular diagnostic services across multiple medical specialties. As a subsidiary of Fulgent Genetics, Inc., the contractor leverages its established expertise in next-generation sequencing and genetic consultation services to provide standardized diagnostic technologies to military personnel and beneficiaries. The BPA framework enables Tripler Army Medical Center to issue task orders on an as-needed basis for genetic testing services, supporting clinical care delivery while maintaining budgetary control through the $950,000 ceiling value. This indefinite delivery vehicle complements the contractor's broader federal healthcare portfolio, which includes significant agreements with the Department of Veterans Affairs and other federal health agencies.
Quick answers
Who was awarded contract W81K0220A0019?
W81K0220A0019 was awarded to Fulgent Therapeutics LLC by Medical Command (Department of the Army) on September 8, 2020.
How much is contract W81K0220A0019 worth?
W81K0220A0019's own ceiling is $950,000. A single order can be worth up to $250,000.
Who can order from contract W81K0220A0019?
W81K0220A0019 is a multiple award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV